About epcoritam ab
CD20×CD3 bispecific antibody
Used for
- Treats adults with relapsed or refractory diffuse large B-cell lymphoma after at least two prior treatments.
Usual adult dose
Given under the skin by a healthcare professional using step-up dosing, then usually weekly, every two weeks, or every four weeks depending on treatment stage.
Common side effects
- Cytokine release syndrome
- Low white blood cells, anemia, or low platelets
- Tiredness, fever, nausea, or diarrhea
- Infections
Important warnings
- Cytokine release syndrome can be severe or life-threatening, especially during initial doses.
- Neurologic toxicity, including immune effector cell-associated neurotoxicity syndrome, can occur.
- Serious infections and low blood counts may occur.
- Treatment requires step-up dosing and monitoring; some patients need preventive medicines or hospital observation.
Pregnancy
May harm an unborn baby. Effective contraception is recommended during treatment and for four months after the last dose.
Breastfeeding
Breastfeeding is not recommended during treatment and for four months after the last dose.
Interactions
- Live vaccines should be avoided during treatment and until immune recovery.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.